buthionine sulfoximine has been researched along with n-methyl-3,4-methylenedioxyamphetamine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Easton, N; Fry, JR; Green, AR; Marsden, CA; O'Shea, E | 1 |
| Ansorena, E; Cenarruzabeitia, E; Iraburu, MJ; López-Zabalza, MJ; Montiel-Duarte, C | 1 |
| Bastos, ML; Branco, PS; Capela, JP; Carvalho, F; Costa, VM; Fernandes, E; Ferreira, LM; Ferreira, PS; Meisel, A; Nogueira, TB | 1 |
3 other study(ies) available for buthionine sulfoximine and n-methyl-3,4-methylenedioxyamphetamine
| Article | Year |
|---|---|
Protection against 3,4-methylenedioxymethamphetamine-induced neurodegeneration produced by glutathione depletion in rats is mediated by attenuation of hyperthermia.
Topics: Animals; Brain; Brain Chemistry; Buthionine Sulfoximine; Drug Therapy, Combination; Fever; Glutathione; Hydroxyindoleacetic Acid; Liver; Male; Maleates; N-Methyl-3,4-methylenedioxyamphetamine; Neurodegenerative Diseases; Paroxetine; Rats; Rats, Inbred Strains; Serotonin; Treatment Outcome | 2002 |
Role of reactive oxygen species, glutathione and NF-kappaB in apoptosis induced by 3,4-methylenedioxymethamphetamine ("Ecstasy") on hepatic stellate cells.
Topics: Acetylcysteine; Animals; Apoptosis; Buthionine Sulfoximine; Cells, Cultured; Drug Interactions; Glutathione; Hepatocytes; N-Methyl-3,4-methylenedioxyamphetamine; NF-kappa B; Oxidative Stress; Quinine; Rats; Reactive Oxygen Species; Stellate Ganglion; Vitamin K 3 | 2004 |
Neurotoxicity of "ecstasy" and its metabolites in human dopaminergic differentiated SH-SY5Y cells.
Topics: 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt; Acetylcysteine; Buthionine Sulfoximine; Cell Death; Cell Differentiation; Cell Line, Tumor; Dipeptides; Dopaminergic Neurons; Enzyme Inhibitors; Free Radical Scavengers; Glutathione; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Neurotoxicity Syndromes; Piperazines | 2013 |